ulrich group banner

Publications

View list on PubMed

View by year:

2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
2003 2002 2001 2000 1999 1998 1996
Time trends in axilla management among early breast cancer patients: Persisting major variation in clinical practice across European centers. Gondos A, Jansen L, Heil J, Schneeweiss A, Voogd AC, Frisell J, Fredriksson I,Johansson U, Tvedskov TF, Jensen MB, Balslev E, Hartmann-Johnsen OJ, Sant M,Baili P, Agresti R, van de Velde T, Broeks A, Nogaret JM, Bourgeois P, Moreau M, Mátrai Z, Sávolt Á, Nagy P, Kásler M, Schrotz-King P, Ulrich C, Brenner H.
Acta Oncol. 2016 Feb
CT-based compartmental quantification of adipose tissue versus body metrics in colorectal cancer patients.
Nattenmueller J, Hoegenauer H, Boehm J, Scherer D, Paskow M, Gigic B, Schrotz-King P, Grenacher L, Ulrich C, Kauczor HU.
Eur Radiol. 2016 Feb 6.

Risk of incident colorectal cancer and death after colonoscopy: a population-based study in Utah.
Samadder NJ, Curtin K, Pappas L, Boucher K, Mineau GP, Smith K, Fraser A, Wan Y, Provenzale D, Kinney AY, Ulrich C, Burt RW.
Clin Gastroenterol Hepatol. 2016 Feb;14(2):279-86.

Resistance Exercise and Inflammation in Breast Cancer Patients Undergoing Adjuvant Radiation Therapy: Mediation Analysis From a Randomized, Controlled Intervention Trial.
Schmidt ME, Meynköhn A, Habermann N, Wiskemann J, Oelmann J, Hof H, Wessels S, Klassen O, Debus J, Potthoff K, Steindorf K, Ulrich CM.
Int J Radiat Oncol Biol Phys. 2016 Feb.

SNPs in transporter and metabolizing genes as predictive markers for oxaliplatin treatment in colorectal cancer patients.
Kap EJ, Seibold P, Scherer D, Habermann N, Balavarca Y, Jansen L, Zucknick M,  Becker N, Hoffmeister M, Ulrich A, Benner A, Ulrich CM, Burwinkel B, Brenner H, Chang-Claude J.
Int J Cancer. 2016 Feb.

International Consortium for End-of-Life Research (ICELR). Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7
Developed Countries.
Bekelman JE, Halpern SD, Blankart CR, Bynum JP, Cohen J, Fowler R, Kaasa S, Kwietniewski L, Melberg HO, Onwuteaka-Philipsen B, Oosterveld-Vlug M, Pring A, Schreyögg J, Ulrich CM, Verne J, Wunsch H, Emanuel EJ.
JAMA. 2016 Jan.

CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk.
Garcia-Albeniz X, Rudolph A, Hutter C, White E, Lin Y, Rosse SA, Figueiredo JC, Harrison TA, Jiao S, Brenner H, Casey G, Hudson TJ, Thornquist M, Le Marchand L, Potter J, Slattery ML, Zanke B, Baron JA, Caan BJ, Chanock SJ, Berndt SI, Stelling D, Fuchs CS, Hoffmeister M, Butterbach K, Du M, James Gauderman W, Gunter MJ, Lemire M, Ogino S, Lin J, Hayes RB, Haile RW, Schoen RE, Warnick GS, Jenkins MA, Thibodeau SN, Schumacher FR, Lindor NM, Kolonel LN, Hopper JL, Gong J, Seminara D, Pflugeisen BM, Ulrich CM, Qu C, Duggan D, Cotterchio M, Campbell PT, Carlson CS, Newcomb PA, Giovannucci E, Hsu L, Chan AT, Peters U, Chang-Claude J.
Br J Cancer. 2016 Jan.

Cancer clinical trial participants' assessment of risk and benefit.
Ulrich CM, Ratcliffe SJ, Wallen GR, Zhou QP, Knafl K, Grady C.
AJOB Empir Bioeth. 2016.

Aspirin Reduces Plasma Concentrations of the Oncometabolite 2-Hydroxyglutarate: Results of a Randomized, Double-Blind, Crossover Trial.
Liesenfeld DB, Botma A, Habermann N, Toth R, Weigel C, Popanda O, Klika KD, Potter JD, Lampe JW, Ulrich CM.
Cancer Epidemiol Biomarkers Prev. 2016 Jan.

Cancer-related fatigue shows a stable association with diurnal cortisol dysregulation in breast cancer patients.
Schmidt ME, Semik J, Habermann N, Wiskemann J, Ulrich CM, Steindorf K.
Brain Behav Immun. 2016 Feb.

A self-regulation-based intervention to increase physical activity in cancer patients.
Ungar N, Sieverding M, Weidner G, Ulrich CM, Wiskemann J.
Psychol Health Med. 2016 Mar.

Familial Risk in Patients With Carcinoma of Unknown Primary.
Samadder NJ, Smith KR, Hanson H, Pimentel R, Wong J, Boucher K, Akerley W, Gilcrease G, Ulrich CM, Burt RW, Curtin K.
JAMA Oncol. 2015 Dec 17.

Cancer clinical trial participants' assessment of risk and benefit.
Ulrich CM, Ratcliffe SJ, Wallen GR, Zhou QP, Knafl K, Grady C.
AJOB Empir Bioeth. 2016.

Mother-caregiver expectations for function among survivors of childhood brain tumors.
Lucas MS, Barakat LP, Ulrich CM, Jones NL, Deatrick JA.
Support Care Cancer. 2015 Nov 10.

Corrigendum: genome-wide association study of colorectal cancer identifies six new susceptibility loci.
Schumacher FR, Schmit SL, Jiao S, Edlund CK, Wang H, Zhang B, Hsu L, Huang SC, Fischer CP, Harju JF, Idos GE, Lejbkowicz F, Manion FJ, McDonnell K, McNeil CE, Melas M, Rennert HS, Shi W, Thomas DC, Van Den Berg DJ, Hutter CM, Aragaki AK, Butterbach K, Caan BJ, Carlson CS, Chanock SJ, Curtis KR, Fuchs CS, Gala M, Giovannucci EL, Gogarten SM, Hayes RB, Henderson B, Hunter DJ, Jackson RD, Kolonel LN, Kooperberg C, Küry S, LaCroix A, Laurie CC, Laurie CA, Lemire M, Levine D, Ma J, Makar KW, Qu C, Taverna D, Ulrich CM, Wu K, Kono S, West DW, Berndt SI, Bezieau S, Brenner H, Campbell PT, Chan AT, Chang-Claude J, Coetzee GA, Conti DV, Duggan D, Figueiredo JC, Fortini BK, Gallinger SJ, Gauderman WJ, Giles G, Green R, Haile R, Harrison TA, Hoffmeister M, Hopper JL, Hudson TJ, Jacobs E, Iwasaki M, Jee SH, Jenkins M, Jia WH, Joshi A, Li L, Lindor NM, Matsuo K, Moreno V, Mukherjee B, Newcomb PA, Potter JD, Raskin L, Rennert G, Rosse S, Severi G, Schoen RE, Seminara D, Shu XO, Slattery ML, Tsugane S, White E, Xiang YB, Zanke BW, Zheng W, Le Marchand L, Casey G, Gruber SB, Peters U.
Nat Commun. 2015 Oct.

Methylation status at HYAL2 predicts overall and progression-free survival of colon cancer patients under 5-FU chemotherapy.
Pfütze K, Benner A, Hoffmeister M, Jansen L, Yang R, Bläker H, Herpel E, Ulrich A, Ulrich CM, Chang-Claude J, Brenner H, Burwinkel B.
Genomics. 2015 Dec.

A self-regulation-based intervention to increase physical activity in cancer patients.
Ungar N, Sieverding M, Weidner G, Ulrich CM, Wiskemann J.
Psychol Health Med. 2016 Mar.

Physical Exercise Training versus Relaxation in Allogeneic stem cell transplantation (PETRA Study) - Rationale and design of a randomized trial to evaluate a yearlong exercise intervention on overall survival and side-effects after allogeneic stem cell transplantation.

Wiskemann J, Kuehl R, Dreger P, Huber G, Kleindienst N, Ulrich CM, Bohus M.
BMC Cancer. 2015 Sep.

Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer.
Hung RJ, Ulrich CM, Goode EL, Brhane Y, Muir K, Chan AT, Marchand LL, Schildkraut J, Witte JS, Eeles R, Boffetta P, Spitz MR, Poirier JG, Rider DN, Fridley BL, Chen Z, Haiman C, Schumacher F, Easton DF, Landi MT, Brennan P, Houlston R, Christiani DC, Field JK, Bickeböller H, Risch A, Kote-Jarai Z, Wiklund F, Grönberg H, Chanock S, Berndt SI, Kraft P, Lindström S, Al Olama AA, Song H, Phelan C, Wentzensen N, Peters U, Slattery ML; GECCO, Sellers TA; FOCI, Casey G, Gruber SB; CORECT, Hunter DJ; DRIVE, Amos CI, Henderson B; GAME-ON Network.
J Natl Cancer Inst. 2015 Aug.

Increased Risk of Colorectal Cancer Among Family Members of All Ages, Regardless of Age of Index Case at Diagnosis.
Samadder NJ, Smith KR, Hanson H, Pimentel R, Wong J, Boucher K, Ahnen D, Singh H, Ulrich CM, Burt RW, Curtin K.
Clin Gastroenterol Hepatol. 2015 Dec.

MethyLight droplet digital PCR for detection and absolute quantification of infrequently methylated alleles.
Yu M, Carter KT, Makar KW, Vickers K, Ulrich CM, Schoen RE, Brenner D, Markowitz SD, Grady WM.
Epigenetics. 2015.

Metabolomics and transcriptomics identify pathway differences between visceral and subcutaneous adipose tissue in colorectal cancer patients: the ColoCare study.
Liesenfeld DB, Grapov D, Fahrmann JF, Salou M, Scherer D, Toth R, Habermann N, Böhm J, Schrotz-King P, Gigic B, Schneider M, Ulrich A, Herpel E, Schirmacher  P, Fiehn O, Lampe JW, Ulrich CM.
Am J Clin Nutr. 2015 Aug.

Genome-wide association study of colorectal cancer identifies six new susceptibility loci. Schumacher FR, Schmit SL, Jiao S, Edlund CK, Wang H, Zhang B, Hsu L, Huang SC, Fischer CP, Harju JF, Idos GE, Lejbkowicz F, Manion FJ, McDonnell K, McNeil CE, Melas M, Rennert HS, Shi W, Thomas DC, Van Den Berg DJ, Hutter CM, Aragaki AK, Butterbach K, Caan BJ, Carlson CS, Chanock SJ, Curtis KR, Fuchs CS, Gala M, Giovannucc EL, Gogarten SM, Hayes RB, Henderson B, Hunter DJ, Jackson RD, Kolonel LN, Kooperberg C, Küry S, LaCroix A, Laurie CC, Laurie CA, Lemire M, Levine D, Ma J, Makar KW, Qu C, Taverna D, Ulrich CM, Wu K, Kono S, West DW, Berndt SI, Bezieau S, Brenner H, Campbell PT, Chan AT, Chang-Claude J, Coetzee GA, Conti DV, Duggan D, Figueiredo JC, Fortini BK, Gallinger SJ, Gauderman WJ, Giles G, Green R, Haile R, Harrison TA, Hoffmeister M, Hopper JL, Hudson TJ, Jacobs E, Iwasaki M, Jee SH, Jenkins M, Jia WH, Joshi A, Li L, Lindor NM, Matsuo K, Moreno V, Mukherjee B, Newcomb PA, Potter JD, Raskin L, Rennert G, Rosse S, Severi G, Schoen RE, Seminara D, Shu XO, Slattery ML, Tsugane S, White E, Xiang YB, Zanke BW, Zheng W, Le Marchand L, Casey G, Gruber SB, Peters U.
Nat Commun. 2015 Jul.
Kury, Sebastian; Giocannucci, Edward L. and Lemire, Mathiew [Corrected to Küry, Sébastien; Giovannucci, Edward L. and Lemire, Mathieu].

Folate-mediated one-carbon metabolism genes and interactions with nutritional factors on colorectal cancer risk: Women's Health Initiative Observational Study.
Cheng TY, Makar KW, Neuhouser ML, Miller JW, Song X, Brown EC, Beresford SA,  Zheng Y, Poole EM, Galbraith RL, Duggan DJ, Habermann N, Bailey LB, Maneval DR, Caudill MA, Toriola AT, Green R, Ulrich CM.
Cancer. 2015 Oct.

Repeat physical activity measurement by accelerometry among colorectal cancer patients--feasibility and minimal number of days of monitoring.
Skender S, Schrotz-King P, Böhm J, Abbenhardt C, Gigic B, Chang-Claude J, Siegel EM, Steindorf K, Ulrich CM.
BMC Res Notes. 2015 Jun 6.

Association between body mass index and mortality for colorectal cancer survivors: overall and by tumor molecular phenotype.
Campbell PT, Newton CC, Newcomb PA, Phipps AI, Ahnen DJ, Baron JA, Buchanan DD, Casey G, Cleary SP, Cotterchio M, Farris AB, Figueiredo JC, Gallinger S, Green RC, Haile RW, Hopper JL, Jenkins MA, Le Marchand L, Makar KW, McLaughlin JR, Potter JD, Renehan AG, Sinicrope FA, Thibodeau SN, Ulrich CM, Win AK, Lindor  NM, Limburg PJ.
Cancer Epidemiol Biomarkers Prev. 2015 Aug.

Mendelian randomization study of height and risk of colorectal cancer.
Thrift AP, Gong J, Peters U, Chang-Claude J, Rudolph A, Slattery ML, Chan AT, Esko T, Wood AR, Yang J, Vedantam S, Gustafsson S, Pers TH; GIANT Consortium, Baron JA, Bezieau S, Küry S, Ogino S, Berndt SI, Casey G, Haile RW, Du M, Harrison TA, Thornquist M, Duggan DJ, Le Marchand L, Lemire M, Lindor NM, Seminara D, Song M, Thibodeau SN, Cotterchio M, Win AK, Jenkins MA, Hopper JL, Ulrich CM, Potter JD, Newcomb PA, Schoen RE, Hoffmeister M, Brenner H, White E, Hsu L, Campbell PT.
Int J Epidemiol. 2015 Apr.

Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk.
Thrift AP, Gong J, Peters U, Chang-Claude J, Rudolph A, Slattery ML, Chan AT, Locke AE, Kahali B, Justice AE, Pers TH, Gallinger S, Hayes RB, Baron JA, Caan BJ, Ogino S, Berndt SI, Chanock SJ, Casey G, Haile RW, Du M, Harrison TA, Thornquist M, Duggan DJ, Le Marchand L, Lindor NM, Seminara D, Song M, Wu K, Thibodeau SN, Cotterchio M, Win AK, Jenkins MA, Hopper JL, Ulrich CM, Potter JD,  Newcomb PA, Hoffmeister M, Brenner H, White E, Hsu L, Campbell PT.
Cancer Epidemiol Biomarkers Prev. 2015 Jul.

Factors influencing participation in a randomized controlled resistance exercise intervention study in breast cancer patients during radiotherapy.
Gollhofer SM, Wiskemann J, Schmidt ME, Klassen O, Ulrich CM, Oelmann J, Hof H, Potthoff K, Steindorf K.
BMC Cancer. 2015 Mar.

Meat intake, cooking methods, dietary carcinogens, and colorectal cancer risk: findings from the Colorectal Cancer Family Registry.
Joshi AD, Kim A, Lewinger JP, Ulrich CM, Potter JD, Cotterchio M, Le Marchand L, Stern MC.
Cancer Med. 2015 Jun.

Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants.
Nan H, Hutter CM, Lin Y, Jacobs EJ, Ulrich CM, White E, Baron JA, Berndt SI, Brenner H, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Casey G, Chang-Claude J, Chanock SJ, Cotterchio M, Duggan D, Figueiredo JC, Fuchs CS, Giovannucci EL, Gong J, Haile RW, Harrison TA, Hayes RB, Hoffmeister M, Hopper JL, Hudson TJ, Jenkins MA, Jiao S, Lindor NM, Lemire M, Le Marchand L, Newcomb PA, Ogino S, Pflugeisen BM, Potter JD, Qu C, Rosse SA, Rudolph A, Schoen RE, Schumacher FR, Seminara D, Slattery ML, Thibodeau SN, Thomas F, Thornquist M, Warnick GS, Zanke BW, Gauderman WJ, Peters U, Hsu L, Chan AT; CCFR; GECCO.
JAMA. 2015 Mar.

Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer.
Kap EJ, Seibold P, Richter S, Scherer D, Habermann N, Balavarca Y, Jansen L, Becker N, Pfütze K, Popanda O, Hoffmeister M, Ulrich A, Benner A, Ulrich CM, Burwinkel B, Brenner H, Chang-Claude J.
Pharmacogenomics J. 2015 Dec.

Establishing good collaborative research practices in the responsible conduct of research in nursing science.
Ulrich CM, Wallen GR, Cui N, Chittams J, Sweet M, Plemmons D.
Nurs Outlook. 2015 Mar-Apr.

Identification of polyphenolic compounds in the flesh of Argan (Morocco) fruits.
Khallouki F, Haubner R, Ricarte I, Erben G, Klika K, Ulrich CM, Owen RW.
Food Chem. 2015 Jul.

Exercise training intensity prescription in breast cancer survivors: validity of current practice and specific recommendations.
Scharhag-Rosenberger F, Kuehl R, Klassen O, Schommer K, Schmidt ME, Ulrich CM, Wiskemann J, Steindorf K.
J Cancer Surviv. 2015 Dec.

Biotransformation of xenobiotics in the human colon and rectum and its association with colorectal cancer.
Beyerle J, Frei E, Stiborova M, Habermann N, Ulrich CM.
Drug Metab Rev. 2015 May.

Cardiopulmonary resuscitation for Ebola patients: ethical considerations.
Ulrich CM, Grady C.
Nurs Outlook. 2015 Jan-Feb.

Red blood cell folate and plasma folate are not associated with risk of incident colorectal cancer in the Women's Health Initiative observational study.
Neuhouser ML, Cheng TY, Beresford SA, Brown E, Song X, Miller JW, Zheng Y, Thomson CA, Shikany JM, Vitolins MZ, Rohan T, Green R, Ulrich CM.
Int J Cancer. 2015 Aug.

Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation.
Bohanes P, Rankin CJ, Blanke CD, Winder T, Ulrich CM, Smalley SR, Rich TA, Martensen JA, Benson AB 3rd, Mayer RJ, Cripps CM, Danenberg K, Makar KW, Zhang W, Benedetti JK, Lenz HJ.
Clin Cancer Res. 2015 Apr.

Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: A randomized controlled trial.
Schmidt ME, Wiskemann J, Armbrust P, Schneeweiss A, Ulrich CM, Steindorf K.
Int J Cancer. 2015 Jul.

What explains the intention to be physically active in cancer patients? Different determinants for active and insufficiently active patients.
Ungar N, Sieverding M, Ulrich CM, Wiskemann J.
J Psychosoc Oncol. 2015.

Exercise intensity classification in cancer patients undergoing allogeneic HCT.
Kuehl R, Scharhag-Rosenberger F, Schommer K, Schmidt ME, Dreger P, Huber G, Bohus M, Ulrich CM, Wiskemann J.
Med Sci Sports Exerc. 2015 May.

No effect of caloric restriction or exercise on radiation repair capacity.
Habermann N, Makar KW, Abbenhardt C, Xiao L, Wang CY, Utsugi HK, Alfano CM, Campbell KL, Duggan C, Foster-Schubert KE, Mason CE, Imayama I, Blackburn GL, Potter JD, McTiernan A, Ulrich CM.
Med Sci Sports Exerc. 2015 May.

Factors influencing willingness for participation in an exercise intervention study in breast cancer patients during radiotherapy.
Gollhoffer SM, Wiskemann J, Schimidt ME, Klassen O, Ulrich CM, Oelmann J, Hof H, Potthoff K, Steindorf K.
BMC Cancer (in press).

Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer.
Kap EJ, Seibold P, Richter S, Scherer D, Habermann N, Balavarca Y, Jansen L, Becker N, Pfutze K, Popanda O, Hoffmeister M, Ulrich A, Benner A, Ulrich CM, Burwinkel B, Brenner H, Chang-Claude J. 
Pharmacogenomics J. 2015 Mar 17.

Exercise training intensity prescription in breast cancer survivors: validity of current practice and specific recommendations.
Scharhag-Rosenberger F, Kuehl R, Klassen O, Schommer K, Schmidt ME, Ulrich CM, Wiskermann J, Steindorf K.
J Cancer Surviv. 2015 Feb 26.

Red blood cell folate and plasma folate are not associated with risk of incident colorectal cancer in the Women’s Health Initiative Observational Study.
Neuhouser ML, Cheng TY, Beresford SAA, Brown E, Song X, Miller JW, Zheng Y, Thomson CA, Shikany JM, Vitolins MZ, Connelly SA, Rohan T, Ulrich CM.
Int J Cancer. 2015 Jan 24.

Global DNA methylation alterations reveal multiple pathways in the initiation and progression of colorectal cancer. 
Luo Y, Wong CJ, Kaz AM, Morris SM, Dzieciatkowski S, Carter KT, Wang J, Willis JE, Makar KW, Ulrich CM, Lutterbaugh JD, Shrubsole MJ, Zheng W, Markowitz SD, Grady WM.
Gastroenterology.

Meat intake, cooking methods, dietary carcinogens and colorectal cancer risk: findings from the Colorectal Cancer Family Registry.
Joshi AD, Kim A, Lewinger JP, Ulrich CM, Potter JD, Cotterchio M, Le Marchand L, Stern MC.
Submitted to Cancer Medicine Journal. (in press)

Exercise training intensity prescription in breast cancer survivors: validity of current practice and specific recommendations.
Scharhag-Rosenberger F, Kuehl R, Klassen O, Schommer K, Schmidt ME, Ulrich CM, Wiskermann J, Steindorf K.
J Cancer Surviv. 2015 Feb 26.

Potential physiologic and molecular mechanisms linking endurance and resistance training with beneficial effects for cancer patients.
Steindorf K, Schmidt ME, Wiskemann J, Ulrich CM.
Submitted to Deutsche Zeitschrift für Sportmedizin. (in press).

No effects of diet and exercise on DNA repair capacity in postmenopausal women – a randomized controlled trial.
Habermann N**, Makar KW, Abbenhardt C, Xiao L, Wang CY, Utsugi HK, Alfano CM, Campbell KL, Duggan C, Foster-Schubert KE, Mason CE, Imayama I, Lampe P, Blackburn GL, Potter JD, McTiernan A, Ulrich CM.
Medicine and Science & Sports and Exercise (in press).

Muscle strength in breast cancer patients receiving different treatment regimes.
Klassen O, Schmidt ME, Ulrich CM, Schneeweiss A, Potthoff K, Steindorf K, Wiskermann J.
Submitted to British Journal of Sports Medicine. (in press)

Prospective study of pre-diagnosis body mass index and colorectal cancer survival, overall and by tumor molecular phenotype.
Campbell PT, Newton CC, Newcomb PA, Phipps AI, Ahnen DJ, Baron JA, Bechanan DD, Casey G, Cleary S, Cotterchio M, Farris AB, Figueiredo JC, Gallinger S, Green RC, Haile RW, Hopper JL, Jenkins MA, Le Marchand L, Makar KW, McLaughlin JR, Potter JD, Renehan A, Sinicrope F, Thibodeau SN, Ulrich CM, Win AK, Lindor NM, Limburg PJ.
Submitted to J Natl Cancer Inst. (in press).

Pharmacogenetic analysis of INT 0144 trial: association of polymorphisms with survival and toxicity in rectal cancer patients treated with 5-FU and radiation. 
Bohanes P, Rankin CJ, Blanke CD, Winder T, Ulrich CM, Smalley SR, Rich TA, Martensen JA, Benson III AB, Mayer RJ, Cripps CM, Danenberg K, Makar KW, Zhang W, Benedetti JK, Lenz HJ.
Submitted to Clin Cancer Res. 2015 Jan 14.

Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants.
Nan H, Hutter CM, Lin Y, Jacobs EJ, Ulrich CM, White E, Baron JA, Berndt SI, Brenner H, Butterback K, Caan BJ, Campbell PT, Carlson CS, Casey G, Chang-Claude J, Chanock SJ, Cotterchio M, Duggan D, Figueiredo JC, Fuchs CS, Giovannucci EL, Gong J, Haile RW, Harrison TA, Hayes RB, Hoffmeister M, Hopper JL, Hudson TJ, Jenkins MA, Jiao S, Lindor NM, Lemire M, Le Marchand L, Newcomb PA, Ogino S, Pflugeisen BM, Potter JD, Qu C, Rosse SA, Rudoph A, Schoen RE, Schemacher FR, Sminara D, Slattery ML, Thibodeau SN, Thomas F, Thornquist M, Warnick GS, Zanke BW, Gauderman WJ, Peters U, Hsu L, Chan AT.
JAMA.
2015 Mar 17; 313(11):1133-42.

adobe

What Explains the Intention to be Physically Active in Cancer Patients? - Different Determinants for Active and Insufficiently Active Patients.
Ungar N, Sieverding M, Ulrich CM, Wiskemann J.
J Phsychosoc Oncol. 2015 Jan 2;33(1):15-33.

adobe

Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: A randomized controlled trial.
Schmidt ME, Wiskemann J, Armbrust P, Schneeweiss A, Ulrich CM, Steindorf K.
Int J Cancer. 2014 Dec 6.

Genetic variants in the GST genes and survival in CRC patients after chemotherapy and differences according to treatment with oxaliplatin.
Kap L, Richter S, Rudolph A, Jansen L, Ulrich A, Hoffmeister M, Ulrich CM, Brenner H, Chang-Claude J. 
Pharmacogenet Genomics. 2014 Jul;24(7):340-7.

adobe

Potential of fecal microbiota for early-stage detection of colorectal cancer
Zeller G, Tap J, Voigt AY, Sunagawa S, Kultima JR, Amiot A, Brunetti F, Costea PI, Habermann N**, Hercog R, Koch M, Luciani A, Mende DR, Schneider MA, Schrotz-King P, Staffa J, Tournigand C, Van Nhieu JT, Yamada T, Zimmermann J, Benes V, Kloor M, Ulrich CM, von Knebel Doeberitz M, Sobhani I, Bork P.
Mol Syst Biol. 2014;28;10:766.

adobe

Plasma Choline Metabolites and Colorectal Cancer Risk in the Women's Health Initiative Observational Study.
Bae, S, Ulrich CM, Neuhouser ML, Malysheva O, Bailey LB, Xiao L, Brown EC, Cuhsing-Haugen KL, Zheng Y, Cheng TY, Miller JW, Green R, Lane DS, Beresford SA, Caudill MA.
Cancer Res. 2014;74:7442-52.

adobe

Randomized, controlled trial of resistance training in breast cancer patients receiving adjuvant radiotherapy: results on cancer-related fatigue and quality of life
Steindorf K, Schmidt ME, Klassen O, Ulrich CM, Oelmann J, Habermann N, Beckhove P, Owen R, Debus J, Wiskemann J, Potthoff K.
Annals Oncol. 2014;25:2237-43.

adobe

No evidence of gene-calcium interactions from genome-wide analysis of colorectal cancer risk.
Du M, Zhang X, Hoffmeister M, Schoen RE, Baron J, Berndt SI, Brenner H, Carlson CS, Casey G, Chan AT, Curtis KR, Duggan D, Gauderman WJ, Giovannucci EL, Gong J, Harrison TA, Hayes RB, Henderson BE, Hopper JL, Hsu L, Hudson TJ, Hutter CM, Jenkins MA, Jiao S, Kocarnik JM, Kolonel LN, Le Marchand L, Lin Y, Newcomb PA, Rudolph A, Seminara D, Thornquist MD, Ulrich CM, White E, Wu K, Zanke BW, Campbell PT, Slattery ML, Peters U, Chang-Claude J, Potter JD.
Cancer Epidemiol Biomarkers Prev. 2014;23:2971-6.

adobe

Suitability of Circulating miRNAs as Potential Prognostic Markers in Colorectal Cancer.
Ristau J, Staffa J, Schrotz-King P, Gigic B, Makar KW, Hoffmeister M, Brenner H, Ulrich A, Schneider M, Ulrich CM, Habermann N.
Cancer Epidemiol Biomarkers Prev. 2014;23:2632-7.

adobe

Translational cancer research: balancing prevention and treatment to combat cancer globally.
Wild CP, Bucher JR, de Jong BW, Dillner J, von Gertten C, Groopman JD, Herceg Z, Holmes E, Holmila R, Olsen JH, Ringborg U, Scalbert A, Shibata T, Smith MT, Ulrich C, Vineis P, McLaughlin J.
J Natl Cancer Inst. 2014 Dec 16;107(1). doi: 10.1093/jnci/dju353. Print 2015 Jan.

adobe

Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among patients with stage II or III rectal cancer (INT-0144; SWOG 9304).
Ulrich CM, Rankin C, Toriola AT, Makar KW, Altug-Teber O, Benedetti JK, Holmes RS, Smalley SR, Blanke CD, Lenz HJ.
Cancer. 2014 Nov 1;120(21):3329-37. Epub 2014 Jul 15.

Differences in DNA methylation signatures reveal multiple pathways of progression.
Luo Y, Wong CJ, Kaz AM, Dzieciatkowski S, Carter KT, Morris SM, Wang J, Willis JE, Makar K, Ulrich CM, Lutterbaugh JD, Shrubsole MJ, Zheng W, Markowitz SD, Grady WM.
Gastroenterology. 2014 Aug;147(2):418-29.e8. Epub 2014 Apr 30.

Ernährung in der Krebsprävention. Aktueller Stand.
Abbenhardt C, Ulrich CM.
FORUM 2014. 29:411–413 (E pub).

Genome-wide diet-gene interaction analyses for risk of colorectal cancer.
Figueiredo JC, Hsu L, Hutter CM, Lin Y, Campbell PT, Baron JA, Berndt SI, Jiao S, Casey G, Fortini B, Chan AT, Cotterchio M, Lemire M, Gallinger S, Harrison TA, Le Marchand L, Newcomb PA, Slattery ML, Caan BJ, Carlson CS, Zanke BW, Rosse SA, Brenner H, Giovannucci EL, Wu K, Chang-Claude J, Chanock SJ, Curtis KR, Duggan D, Gong J, Haile RW, Hayes RB, Hoffmeister M, Hopper JL, Jenkins MA, Kolonel LN, Qu C, Rudolph A, Schoen RE, Schumacher FR, Seminara D, Stelling DL, Thibodeau SN, Thornquist M, Warnick GS, Henderson BE, Ulrich CM, Gauderman WJ, Potter JD, White E, Peters U.
PLoS Genet. 2014;10:e1004228.

adobe

Genetic variation in prostaglandin synthesis and related pathways, NSAID use and colorectal cancer risk in the Colon Cancer Family Registry.
Resler A**, Makar KW, Heath L, Whitton J, Potter JD, Poole EM, Habermann N, Scherer D, Duggan D, Wang H, Lindor NM, Passarelli MN, Baron JA, Newcomb PA, LeMarchand L, Ulrich CM.
Carcinogenesis. 2014;35:2121-6.

adobe

Gene-environment interaction involving recently identified colorectal cancer susceptibility Loci.
Kantor ED, Hutter CM, Minnier J, Berndt SI, Brenner H, Caan BJ, Campbell PT, Carlson CS, Casey G, Chan AT, Chang-Claude J, Chanock SJ, Cotterchio M, Du M, Duggan D, Fuchs CS, Giovannucci EL, Gong J, Harrison TA, Hayes RB, Henderson BE, Hoffmeister M, Hopper JL, Jenkins MA, Jiao S, Kolonel LN, Le Marchand L, Lemire M, Ma J, Newcomb PA, Ochs-Balcom HM, Pflugeisen BM, Potter JD, Rudolph A, Schoen RE, Seminara D, Slattery ML, Stelling DL, Thomas F, Thornquist M, Ulrich CM, Warnick GS, Zanke BW, Peters U, Hsu L, White E.
Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1824-33. Epub 2014 Jul 3.

adobe

Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registry.
Scherer D, Koepl LM, Poole EM, Balavarca Y, Xiao L, Baron JA, Hsu L, Coghill AE, Campbell PT, Kleinstein SE, Figueiredo JC, Lampe JW, Buck K, Potter JD, Kulmacz RJ, Jenkins MA, Hopper JL, Win AK, Newcomb PA, Ulrich CM, Makar KW.
Genes Chromosomes Cancer. 2014 Jul;53(7):568-78. Epub 2014 Mar 28

adobe

Biomarkers of one-carbon metabolism are associated with biomarkers of inflammation in women.
Abbenhardt C, Miller JW, Song X, Brown EC, Cheng TY, Wener MH, Zheng Y, Toriola AT, Neuhouser ML, Beresford SA, Makar KW, Bailey LB, Maneval DR, Green R, Manson JE, Van Horn L, Ulrich CM.
J Nutr. 2014 May;144(5):714-21. Epub 2014 Mar 19.

Consideration of family history of cancer in medical routine: a survey in the primary care setting in Germany.
Fiederling J, Ulrich CM, Hemminki K, Haug U.
Eur J Cancer Prev. 2014;23:199-205.

adobe

Efficacy of exercise training in SCT patients--who benefits most?
Wiskemann J, Kuehl R, Dreger P, Schwerdtfeger R, Huber G, Ulrich CM, Jaeger D, Bohus M.
Bone Marrow Transplant. 2014 Mar;49(3):443-8. Epub 2013 Dec 9.

Counseling patients on cancer diets: a review of the literature and recommendations for clinical practice.
Huebner J, Marienfeld S, Abbenhardt C, Ulrich CM, Muenstedt K, Micke O, Muecke R., Loeser C.
Anticancer Res. 2014;34:39-48.

Physical performance and psychosocial status in lung cancer patients: results from a pilot study.
Hummler S, Thomas M, Hoffmann B, Gartner P, Zoz M, Huber G, Ulrich CM, Wiskemann J.
Oncol Res Treat. 2014;37:36-41.

Exercise in patients with non-small cell lung cancer (NSCLC).
Kuehr L, Wiskemann J, Abel U, Ulrich CM, Hummler S, Thomas M.
Med Sci Sports Exerc. 2014;46:656-63.

Predictors of adherence to a 26-week yoga intervention among post-treatment breast cancer survivors.
Cadmus L, McTiernan A, Ulrich CM, Stovall R, Ceballos R, McGregor B, Ramaprasad J, Littmann AJ.
J Altern Complement Med. 2013 Sep;19(9):751-8.

Identification of genetic susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.
Peters U, Jiao S, Schumacher FR, Hutter CM, Aragaki AK, Baron JA, Berndt SI, Bézieau S, Brenner H, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Casey G, Chan AT, Chang-Claude J, Chanock SJ, Chen LS, Coetzee GA, Coetzee SG, Conti DV, Curtis KR, Duggan D, Edwards T, Fuchs CS, Gallinger S, Giovannucci EL, Gogarten SM, Gruber SB, Haile RW, Harrison TA, Hayes RB, Henderson BE, Hoffmeister M, Hopper JL, Hudson TJ, Hunter DJ, Jackson RD, Jee SH, Jenkins MA, Jia WH, Kolonel LN, Kooperberg C, Küry S, Lacroix AZ, Laurie CC, Laurie CA, Le Marchand L, Lemire M, Levine D, Lindor NM, Liu ML, Taverna D, Thibodeau SN, Ulrich CM, White E, Xiang Y, Zanke BW, Zeng YX, Zhang B, Zheng W, Hsu L. 
Gastroenterology. 2013;144:799-807.e24.

Specialty supplement use and biologic measures of oxidative stress and DNA damage.
Kantor ED, Ulrich CM, Owen RW, Schmezer P, Neuhouser ML, Lampe JW, Peters U, Shen DD, Vaughan TL, White E.
Cancer Epidemiol Biomarkers Prev. 2013;22:2312-22.

Review of mass spectrometry-based metabolomics in cancer research.
Liesenfeld DB, Habermann N, Owen RW, Scalbert A, Ulrich CM.
Cancer Epidemiol Biomarkers Prev. 2013;22:2182-201.

COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations.
Makar KW, Poole EM, Resler AJ, Seufert B, Curtin K, Kleinstein SE, Duggan D, Kulmacz RJ, Hsu L, Whitton J, Carlson CS, Rimorin CF, Caan BJ, Baron JA, Potter JD, Slattery ML, Ulrich CM.
Cancer Causes Control. 2013;24:2059-75.

Impact of folic acid fortification on global DNA methylation and one-carbon biomarkers in the Women's Health Initiative Observational Study cohort.
Bae S, Ulrich CM, Bailey LB, Malysheva O, Brown EC, Maneval DR, Neuhouser, M, Cheng T-YD, Miller JW, Zheng Y, Xiao L, Hou L, Song X, Buck K, Beresford AA, Caudill MA.
Epigenetics. 2014;9:396-403.

Progressive resistance versus relaxation training for breast cancer patients during adjuvant chemotherapy: design and rationale of a randomized controlled trial (BEATE study).
Schmidt ME, Wiskemann J, Krakowski-Roosen H, Knicker AJ, Habermann N, Schneeweiss A, Ulrich CM, Steindorf K.
Contemp Clin Trials. 2013;34:117-25.

Folate and health: present and future.
Ulrich CM, Miller JW.
Mol Nutr Food Res. 2013;57:561.

Spray-drying encapsulation of mangiferin using natural polymers.
De Souza JRR, Feitosa JPA, Ricardo NMPS, Trevisan MTS, de Paula HCB, Ulrich CM, Owen RW.
Food Hydrocolloids. 2013;33:10-18.

Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue.
Sherwood AM, Emerson O, Scherer D, Habermann N, Buck K, Staffa J, Desmarais C, Halama N, Jäger D, Schirmacher P, Herpel E, Kloor M, Ulrich A, Schneider M, Ulrich CM*, Robins H*; *dual senior authorship.
Cancer Immunol Immunother. 2013;62:1453-61.

Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multi-ethnic cohort of breast cancer survivors.
Villaseñor A, Ballard-Barbash R, Ambs A, Bernstein L, Baumgartner K, Baumgartner R, Ulrich CM, Hollis BW, McTiernan A, Neuhouser ML. 
Cancer Causes Control. 2013;24:759-67.

Genetic variation in the lipoxygenase pathway and risk of colorectal neoplasia.
Kleinstein SE**, Heath L, Makar KW, Poole EM, Seufert BL, Slattery ML, Xiao L, Duggan DJ, Hsu L, Curtin K, Heath L, Koepl L, Muehling J, Taverna D, Caan B, Carlson CS, Potter JD, Ulrich CM.
Genes Chromosomes Cancer. 2013;52:437-49.

Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers.
Toriola AT**, Cheng T-YD, Neuhouser ML, Wener MH, Zheng Y, Brown E, Miller JW, Song X, Beresford SA, Gunter MJ, Caudill MA, Ulrich CM.
Int J Cancer. 2013;132:2648-58.

Predictors of adherence to a 26-week Viniyoga yoga intervention among post-treatment breast cancer survivors.
Cadmus-Bertram L, Littman A, Ulrich CM, Stovall R, Ceballos R, McGregor B, Wang CY, Ramaprasad J, McTiernan A.
J Altern Complement Med. 2013;19:751-8.

Gene-diet-interactions in folate-mediated one-carbon metabolism modify colon cancer risk.
Liu AY**, Scherer D, Poole E, Potter JD, Curtin K, Makar K, Slattery ML, Caan BJ, Ulrich CM.
Mol Nutr Food Res. 2013;57:721-34.

Anacardic acids from cashew nuts ameliorates lung damage induced by exposure to diesel exhaust particles in mice.
Carvalho AL, Annoni R, Larissa Torres LH, Durão AC, Shimada AL, Almeida FM, Hebeda CB, Lopes FD, Dolhnikoff M, Martins MA, Silva LF, Farsky SH, Saldiva PH, Marcourakis T, Trevisan MT, Ulrich CM, Owen RW, Mauad T.
Evid Based Compliment Alternat Med. 2013;2013:549879.

Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia.
Abbenhardt C**, Poole E, Xiao L, Curtin K, Galbraith R, Duggan D, Hsu L, Makar K, Kulmacz R, Potter J, Caan B, Koepl L, Coghill A, Muehling J, Taverna D, Carlson C, Slattery M, Ulrich CM.
Int J Mol Epidemiol Genet. 2013;4:140-149.

Genetic variation in the inflammation and innate immunity pathways and colorectal cancer risk.
Wang H, Taverna D, Stram D, Chang I, Wilkens L, Burnett T, Makar KW, Lindor NM, Hopper JL, Gallinger S, Baron J, Haile R, Kolonel L, Henderson BE, Newcomb P, Duggan D, Ulrich CM, Le Marchand L.
Cancer Epidemiol Biomarkers Prev. 2013;22:2094-2101.

Homocysteine, cysteine and risk of incident colorectal cancer in the Women’s Health Initiative Observational Cohort.
Miller JW, Beresford SAA, Neuhouser ML, Cheng TY, Song X, Brown EC, Zheng Y, Rodriguez B, Green R, Ulrich CM.
Am J Clin Nutr. 2013;97:827-834.
Impact of genetic polymorphisms on adenoma recurrence and toxicity in a COX2 inhibitor (celecoxib) trial: results from a pilot study.
Kraus S, Hummler S, Toriola AT, Poole EM, Scherer D, Kotzmann J, Makar KW, Kazanow D, Galazan L, Naumov I, Coghill AE, Duggan D, Gigic B, Arber N, Ulrich CM.
Pharmacogenet Genomics. 2013;23:428-437.
Impact of resistance training in cancer survivors: a meta-analysis.
Strasser B, Steindorf K, Wiskemann J, Ulrich CM.
Med Sci Sports Exerc. 2013;45:2080-2090

Randomized controlled trial to evaluate the effects of progressive resistance training compared to progressive muscle relaxation in breast cancer patients undergoing adjuvant radiotherapy: The BEST Study.
Potthoff K, Schmidt M, Wiskemann J, Hof H, Klassen O, Habermann N, Beckhove P, Debus J, Ulrich CM, Steindorf K.
BMC Cancer. 2013;13:162

Effects of individual and combined dietary weight loss and exercise interventions in postmenopausal women on adiponectin and leptin levels.
Abbenhardt, C**, McTiernan A, Alfano CM, Wener MH, Campbell KL, Duggan C, Foster-Schubert KE, Kong A, Toriola AT, Potter JD, Mason C, Xiao L, Blackburn GL, Bain C, Ulrich CM.
J Intern Med. 2013;274:163-175.

Plasma 25-hydroxyvitamin D3, folate and vitamin B12 biomarkers among international colorectal cancer patients: a pilot study.
Ulrich CM, Toriola AT, Siegel EM, Brenner H, Chang-Claude J, Abbenhardt C, Kotzmann J, Song X, Owen RW, Hoffmeister M, Becher H, Shibata D, Vickers K, Rush S, Makar KW, Würtele G, Haubner R, Sellers TA, Grady W.
J Nutr Sci. 2013;2:e9.

Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research.
Elena J, Travis L, Simonds N, Ambrosone C, Ballard-Barbash R, Bhatia S, Cerhan J, Hartge P, Heist R, Kushi L, Lash T, Morton L, Onel K, Pierce J, Robison L, Rowland J, Schrag D, Sellers T, Seminara D, Shu XO, Thomas N, Ulrich CM, Freedman A.
J Natl Cancer Inst. 2013;105:85-94.

Gene-expression changes in adipose tissue with diet- and/or exercise-induced weight loss.
Campbell K**, Foster-Schubert K, Makar K, Kratz M, Hagman D, Schur E, Habermann N, Horton M, Abbenhardt C, Kuan L, Xiao L, Davison J, Morgan M, Wang C, Duggan C, McTiernan A, Ulrich CM.
Cancer Prev Res (Phila). 2013;6:217-231.

Folic acid and cancer - where are we today?
Miller JW, Ulrich CM.
The Lancet. 2013;381:974 – 976

PTGS1, PTGS2, ALOX5, ALOX12, ALOX15, and FLAP SNPs: interaction with fatty acids in colon cancer and rectal cancer.
Habermann N, Ulrich CM, Lundgreen A, Makar KW, Poole EM, Bette Caan, Kulmacz R, Whitton J, Galbraith R, Potter JD, Slattery ML.
Genes Nutr. 2013;8:115-126.

CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment.
Barry EL, Poole E, Baron JA, Makar KW, Mott LA, Sandler RS, Ahnen DJ, Bresalier RS, McKeown-Eyssen GE, Ulrich CM.
Cancer Causes Control. 2013;24:47-54.

History of weight cycling does not impede future weight loss or metabolic improvements in postmenopausal women.
Mason C, Foster-Schubert KE, Imayama I, Xiao L, Kong A, Campbell KL, Duggan CR, Wang CY, Alfano CM, Ulrich CM, Blackburn GL, McTiernan A.
Metabolism. 2013;62:127-136.

IkBKb and NFkB1, NSAID use and risk of colorectal cancer in the Colon Cancer Family Registry.
Seufert BL, Poole EM, Whitton J, Xiao L, Makar KM, Campbell PT, Kulmacz RJ, Baron JA, Newcomb PA, Slattery ML, Potter JD, Ulrich CM.
Carcinogenesis. 2013;34:79-85.

B vitamin intakes and incidence of colorectal cancer: Results from the Women’s Health Initiative Observational Study Cohort.
Zschäbitz S**, Cheng T-YD, Neuhouser ML, Zheng Y, Ray RM, Miller JW, Song X, Bailey LB, Maneval DR, Beresford SA, Lane D, Shikany JM, Ulrich CM.
Am J Clin Nutr. 2013;97:332-343.

Genome-wide search for gene-gene interactions in colorectal cancer.
Jiao S, Hsu L, Berndt S, Bézieau S, Brenner H, Buchanan D, Caan BJ, Carlson CS, Casey G, Chan AT, Chang-Claude J, Chanock S, Conti DV, Curtis KR, Duggan D, Gallinger S, Gruber SB, Harrison TA, Hayes RB, Henderson BE, Hoffmeister M, Hopper JL, Hudson TJ, Hutter CM, Jackson RD, Jenkins MA, Kantor ED, Kolonel LN, Küry S, Marchand LL, Lemire M, Newcomb PA, Potter JD, Qu C, Rosse SA, Schoen RE, Schumacher FR, Seminara D, Slattery ML, Ulrich CM, Zanke BW, Peters U.
PLoS One. 2012;7(12):e52535. Epub 2012 Dec 26.

Wie sinnvoll sind “Krebsdiäten”? Eine kritische Analyse als Grundlage für die ärztliche Beratung.
Hübner J, Marienfeld S, Abbenhardt C, Ulrich CM, Löser C.
Dtsch Med Wochenschr 2012;137:2417-2422. 

Metabolic, hormonal and immunological associations with global DNA methylation among postmenopausal women.
Ulrich CM, Toriola AT, Koepl LM, Sandifer T, Poole EM, Duggan C, McTiernan A, Issa JP.
Epigenetics. 2012;7:1020-1028.           

DEXA measures of body fat percentage and acute phase proteins among breast cancer survivors: A cross-sectional analysis.
Dee A, McKean-Cowdin R, Neuhouser M, Ulrich CM, Baumgartner R, McTiernan A, Baumgartner K, Alfano C, Ballard-Barbash R, Bernstein L.
BMC Cancer. 2012;12:343.

Characterization of gene-environment interactions for previously identified colorectal cancer susceptibility loci.
Hutter CM, Chang-Claude J, Slattery M, Pflugeisen B, Lin Y, Duggan D, Nan H, Lemire M, Rangrej J, Jiao S, Harrison T, Liu Y, Chen L, Stelling D, Warnick G, Hofmeister M, Kuery S, Fuchs CS, Giovannucci E, Hazra A, Kraft P, Hunter D, Gallinger S, Zanke B, Brenner H, Frank B, Ma J, Ulrich CM, White E, Newcomb PA, Kooperberg C, LaCroix A, Prentice R, Jackson R, Schoen R, Chanock S, Berndt S, Hayes R, Caan B, Potter J, Hsu L, Bezieau S, Chan A, Hudson T, Peters U.
Cancer Res. 2012;72:2036-2044.

Functional analysis of human thromboxane synthase polymorphic variants.
Chen C-YK, Poole EM, Ulrich CM, Kulmacz RJ, Wang L-H.
Pharmacogenet Genomics. 2012;22:653-658.

Decreased cyclooxygenase inhibition by aspirin in polymorphic variants of human prostaglandin H synthase-1.
Liu W, Poole EM, Ulrich CM, Kulmacz RJ.
Pharmacogenet Genomics. 2012;22:525-537.

A comparison of approaches for association studies of polymorphisms and colorectal cancer risk.
Ramsey SD, Holmes RS, McDermott CL, Blough DK, Petrin KL, Poole EM, Ulrich CM.
Colorectal Dis. 2012;14:e573-586.

Glutathione peroxidase (GPX) tagSNPs: Associations with rectal, but not with colon cancer.
Haug U**, Poole EM, Xiao L, Curtin K, Duggan D, Hsu L, Makar K, Peters U, Kulmacz R, Potter J, Koepl L, Caan B, Slattery M, Ulrich CM.
Genes Chromosomes Cancer. 2012;51:598-605.

Adiposity, body composition, and weight change in relation to organochlorine pollutant plasma concentrations.
De Roos AJ, Ulrich CM, Sjodin A, McTiernan A.
J Expo Sci Environ Epidemiol. 2012;22:617-624.       

Phytochemical composition and antioxidant capacity of various botanical parts of the fruits of Prunus x domestica L. from the Lorraine region of France.
Khallouki F, Haubner R, Erben G, Ulrich CM, Owen RW.
Food Chemistry. 2012;133:697-706.

Injuries in sedentary individuals enrolled in a 12-month randomized controlled exercise trial.
Campbell K, Foster-Schubert K, Alfano C, Cadmus L, Xiao L, Duggan C, Irwin M, Ulrich CM, McTiernan A.
J Phys Act Health. 2012;9:198-207.

Fatigue, inflammation, and omega-3 and omega-6 fatty acid intake among breast cancer survivors.
Alfano CM, Imayama I, Neuhouser ML, Kiecolt-Glaser JK, Wilder Smith A, Meeske K, McTiernan A, Bernstein L, Baumgartner KB, Ulrich CM, Ballard-Barbash R.
J Clin Oncol. 2012;30:1280-1287.

Isolation and characterization of ellagitannins as the major polyphenolic components of Longan (Dimocarpus longan Lour) seeds.
Sudjaroen Y, Hull WE, Erben G, Wurtele G, Changbumrung S, Ulrich CM, Owen RW.
Phytochemistry. 2012;77:226-237.

Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial.
Imayama I**, Ulrich CM, Alfano CM, Wang C, Xiao L, Wener MH, Campbell KL, Duggan C, Foster-Schubert KE, Kong A, Mason CE, Wang C-Y, Blackburn GL, Bain CE, Thompson HJ, McTiernan A.
Cancer Res. 2012;72:2314-26.

Krebsprävention durch Lebensstil – was ist evidenzbasiert?
Ulrich CM, Steindorf K.
Der Onkologe 2012;18:192-7.

Randomized controlled pilot trial of yoga in overweight and obese breast cancer survivors: effects on quality of life and anthropometric measures.
Littman AJ, Bertram LC, Ceballos R, Ulrich CM, Ramaprasad J, McGregor B, McTiernan A.
Support Care Cancer. 2012;20:267-277.

Meta-analysis of new genome-wide association studies of colorectal cancer risk.
Peters U, Hutter CM, Hsu L, Schumacher FR, Conti DV, Carlson CS, Edlund CK, Haile RW, Gallinger S, Zanke BW, Lemire M, Rangrej J, Vijayaraghavan R, Chan AT, Hazra A, Hunter DJ, Ma J, Fuchs CS, Giovannucci EL, Kraft P, Liu Y, Chen L, Jiao S, Makar KW, Taverna D, Gruber SB, Rennert G, Moreno V, Ulrich CM, Woods MO, Green RC, Parfrey PS, Prentice RL, Kooperberg C, Jackson RD, Lacroix AZ, Caan BJ, Hayes RB, Berndt SI, Chanock SJ, Schoen RE, Chang-Claude J, Hoffmeister M, Brenner H, Frank B, Bezieau S, Kury S, Slattery ML, Hopper JL, Jenkins MA, Le Marchand L, Lindor NM, Newcomb PA, Seminara D, Hudson TJ, Duggan DJ, Potter JD, Casey G.
Hum Genet. 2012;131:217-34.

Welche Effekte hat körperliche Bewegung auf das Krebsrisiko und auf den Krankheitsverlauf nach einer Krebsdiagnose?
Steindorf K, Schmidt M, Ulrich CM.
Bundesgesundheitsblatt. 2012;55(1):10-16.

Physiologische und molekulare Mechanismen der Wirkung von körperlicher Aktivität auf das Krebsrisiko und den Verlauf einer Krebserkrankung.
Ulrich CM, Wiskemann J, Steindorf K.
Bundesgesundheitsblatt. 2012;55(1):3-9.

Genetic variability in IL23R and risk of colorectal adenoma and colorectal cancer.
Poole EM**, Curtin K, Hsu L, J DD, Makar KW, Xiao L, Carlson CS, Caan BJ, Potter JD, Slattery ML, Ulrich CM.
Cancer Epidemiol. 2012;36:e104-e110.

Effekte körperlichen Trainings auf die Psyche von Krebspatienten.
Wiskemann J, Ulrich CM, Steindorf K.
Forum (Deutsche Krebsgesellschaft) 2011;26:42-8.

Fine particulate matter (PM(2.5)) air pollution and immune status among women in the Seattle area.
Williams L, Ulrich CM, Larson T, Wener MH, Wood B, Chen-Levy Z, Campbell PT, Potter J, McTiernan A, De Roos AJ.
Arch Environ Occup Health. 2011;66:155-65.

Ethnobotanical survey, chemical composition, and antioxidant capacity of methanolic extract of the root bark of annona cuneata oliv.
Khallouki F, Haubner R, Ulrich CM, Owen RW.
J Med Food. 2011;14:1397-402..

Genetic variation in inflammatory pathways is related to colorectal cancer survival.
Coghill AE**, Newcomb PA, Poole EM, Hutter CM, Makar KW, Duggan D, Potter JD, Ulrich CM.
Clin Cancer Res. 2011;17:7139-7147

Genetic variability in EGFR, Src and HER2 and risk of colorectal adenoma and cancer.
Poole EM**, Curtin K, Hsu L, Kulmacz RJ, Duggan DJ, Makar KW, Xiao L, Carlson CS, Slattery ML, Caan BJ, Potter JD, Ulrich CM.
Int J Mol Epidemiol Genet. 2011;2:300-315.

Dietary weight loss and exercise effects on insulin resistance in postmenopausal women.
Mason C, Foster-Schubert KE, Imayama I, Kong A, Xiao L, Bain C, Campbell KL, Wang CY, Duggan CR, Ulrich CM, Alfano CM, Blackburn GL, McTiernan A.
Am J Prev Med. 2011;41:366-375.

Dietary fiber is associated with circulating concentrations of C-reactive protein in breast cancer survivors: the HEAL study.
Villasenor A, Ambs A, Ballard-Barbash R, Baumgartner KB, McTiernan A, Ulrich CM, Neuhouser ML.
Breast Cancer Res Treat. 2011;129:485-494.

A 12-month moderate-intensity exercise intervention does not alter serum prolactin concentrations.
Reding KW, Lampe JW, Wang CY, Stanczyk FZ, Ulrich CM, Xiao L, Duggan CR, McTiernan A.
Cancer Epidemiol. 2011;35:569-573.

PharmGKB summary: methotrexate pathway.
Mikkelsen TS, Thorn CF, Yang JJ, Ulrich CM, French D, Zaza G, Dunnenberger HM, Marsh S, McLeod HL, Giacomini K, Becker ML, Gaedigk R, Leeder JS, Kager L, Relling MV, Evans W, Klein TE, Altman RB.
Pharmacogenet Genomics. 2011;21:679-686.

Is there a potential use for C-reactive protein as a diagnostic and prognostic marker for colorectal cancer?
Toriola AT**, Ulrich CM.
Future Oncol. 2011;7:1125-1128.

Polymorphic human prostaglandin H synthase-2 proteins and their interactions with cyclooxygenase substrates and inhibitors.
Liu W, Poole EM, Ulrich CM, Kulmacz RJ.
Pharmacogenomics J 2011;11:337-47.

Mathematical modeling predicts the effect of folate deficiency and excess on cancer- related biomarkers.
Neuhouser M, Nijhout H, Gregory, JF III, Reed M, James SJ, Liu A, Shane B, Ulrich CM.
Cancer Epidemiol Biomarkers Prev 2011;20:1912-1917.

Nachsorge, Komplikationen und deren Therapie bei der operativen, strahlentherapeutischen und medikamentösen Therapie des Lungenkarzinoms.
Armbrecht A, Groschel A, Pottgen C, Reck M, Ruffer JU, Seifart U, Ulrich CM, Winter H.
Onkologie 2011;34 Suppl 4:11-6.

Polymorphisms in WNT6 and WNT10A and colorectal adenoma risk.
Galbraith RL**, Poole EM, Duggan D, Muehling J, Hsu L, Makar K, Xiao L, Potter JD, Ulrich CM.
Nutr Cancer 2011; 63:558-64.

Nutrients in folate-mediated, one-carbon metabolism and the risk of rectal tumors in men and women.
Curtin K, Samowitz WS, Ulrich CM, Wolff RK, Herrick JS, Caan BJ, Slattery ML.
Nutr Cancer 2011; 63:357-66.

Postdiagnosis diet quality, the combination of diet quality and recreational physical activity, and prognosis after early-stage breast cancer.
George SM, Irwin ML, Smith AW, Neuhouser ML, Reedy J, McTiernan A, Alfano CM, Bernstein L, Ulrich CM, Baumgartner KB, Moore SC, Albanes D, Mayne ST, Gail MH, Ballard-Barbash R.
Cancer Causes Control; 2011; 22:589-98.

Effects of a partly self-administered exercise program before, during and after allogeneic stem cell transplantation.
Wiskemann J, Dreger P, Schwerdtfeger R, Bondong A, Huber G, Ulrich CM, Bohus M.
Blood 2011, 117:2604-13.

Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer.
Coghill AE**, Newcomb PA, Campbell PT, Burnett-Hartman AN, Adams SV, Poole EM, Potter JD, Ulrich CM.
Gut 2011; 60:491-8.

Genetic variation in C-reactive protein (CRP) in relation to colon and rectal cancer risk and survival.
Slattery ML, Curtin K, Poole E, Duggan DJ, Wade SS, Peters U, Caan BJ, Potter JD, Ulrich CM.
International Journal of Cancer 2011, 128:2726-34.

Cohorts and consortia conference: a summary report (Banff, Canada, June 17-19, 2009).
Boffetta P, Colditz GA, Potter JD, Kolonel L, Robson PJ, Malekzadeh R, Seminara D, Goode EL, Yoo KY, Demers P, Gallagher R, Prentice R, Yasui Y, O'Doherty K, Petersen GM, Ulrich CM, Csizmadi I, Amankwah EK, Brockton NT, Kopciuk K, McGregor SE, Kelemen LE.
Cancer Causes Control 2011; 22:463-8.

Linking epidemiology to epigenomics - where are we today?
Ulrich CM, Grady WM.
Cancer Prevention Research 2010 Dec; 3:1505-8.

Cancer Pharmocogenomics and Pharmacoepidemiology: Setting a research agenda to accelerate translation.
Freedman AN, Sansbury LB, Figg WD, Potosky AL, Weiss Smith SR, Khoury MJ, Nelson S, Weinshilboum RM, Ratain MJ, McLeod H, Epstein RS, Ginsburg GS, Schilsky R, Liu G, Flockhart DA, Ulrich CM, Long RM, Davis RL, Lesko LJ, Zineh I, Randhawa G, Ambrosone CB, Relling M, Rothman N, Xie H, Spitz M, Ballard-Barbash R, Mitnasian L.
Journal of the National Cancer Institute 2010; 102:1698-1705.

Postdiagnosis diet quality is inversely related to a biomarker of inflammation among breast cancer survivors.
George SM, Neuhouser ML, Mayne ST, Irwin ML, Albanes D, Gail MH, Alfano CM, Bernstein L, McTiernan A, Reedy J, Smith AW, Ulrich CM, Ballard-Barbash R.
Cancer Epidemiol Biomarkers Prev 2010; 19:2220-8.

Confirmation of linkage to and localization of familial colon cancer risk haplotype on chromosome 9q22.
Gray-McGuire C, Guda K, Adrianto I, Lin CP, Natale L, Potter JD, Newcomb P, Poole EM, Ulrich CM, Lindor N, Goode EL, Fridley BL, Jenkins R, Le Marchand L, Casey G, Haile R, Hopper J, Gallinger S, Baron JA, Adams M, Willis J, Elston R, Markowitz SD, Wiesner GL.
Cancer Research 2010; 70(13):5409-5418.

Use of folic acid-containing supplements after a diagnosis of colorectal cancer in the Colon Cancer Family Registry.
Holmes RS**, Zheng Y, Baron JA, Li L, McKeown-Eyssen G, Newcomb PA, Stern MC, Haile RW, Grady WM, Potter JD, Le Marchand L, Campbell PT,  Figueiredo JC,  Limburg PJ, Jenkins MA, Hopper JL and Ulrich CM.
Cancer Epidemiology, Biomarkers & Prevention 2010; 19(8): 2023-2024.

A candidate gene study of folate-associated one carbon metabolism genes and colorectal cancer risk.
Levine AJ, Figueiredo J, Lee W, Conti DV, Kennedy K, Duggan DJ, Poynter JN, Campbell PT, Newcomb P, Martinez ME, Hopper JL, Marchand L, Baron JA, Limburg PJ, Ulrich CM, Haile RW.
Cancer Epidemiology, Biomarkers, & Prevention 2010; 19(7): 1812-1821.

Frequent intentional weight loss is associated with higher ghrelin and lower glucose and androgen levels in postmenopausal women.
Hooper LE**, Foster-Schubert KE, Weigle DS, Sorensen B, McTiernan A, Ulrich CM.
Nutrition Research 2010; 30:163-170.

DNA damage and repair: fruit and vegetable effects in a feeding trial.
Chang JL, Chen G, Ulrich CM, Bigler J, King IB, Schwartz Y, Li S, Potter JD, Lampe JW.
Nutrition and Cancer 2010; 62:329-35.

Effect of exercise on oxidative stress: a 12-month randomized, controlled trial.
Campbell PT**, Gross MD, Potter JD, Schmitz KH, Duggan C, McTiernan A, Ulrich CM.
Med Sci Sports Exerc 2010; 42(8): 1448-1453.

Case-control study of obesity, overweight and colorectal cancer risk, overall and by tumor microsatellite instability status.
Campbell PT**, Jacobs ET, Ulrich CM, Figueiredo JC, Poynter JN, McLaughlin JR, Haile RW, Jacobs EJ, Newcomb PA, Potter JD, Le Marchand L, Green RC, Parfrey P, Younghusband HB, Cotterchio M, Gallinger S, Jenkins MA, Hopper JL, Baron JA, Thibodeau SN, Lindor NM, Limburg PJ, Martinez ME, for the Colon Cancer Family Registry.
Journal of the National Cancer Institute 2010; 102 (6):391-400.

Genetic Variability in the MTHFR gene and colorectal cancer risk using the Colorectal Cancer Family Registry.
Levine AJ, Figueiredo JC, Lee W, Poynter JN, Conti D, Duggan DJ, Campbell PT, Newcomb P, Martinez ME, Hopper JL, LeMarchand L, Baron JA, Limburg PJ, Ulrich CM, Haile RW.
Cancer Epidemiology, Biomarkers and Prevention 2010; 19:89-100.

Genetic variation in prostaglandin E2 synthesis and signaling, prostaglandin dehydrogenase, and risk of colorectal adenoma.
Poole EM**, Hsu L, Xiao L, Kulmacz RJ, Carlson CS, Rabinovitch PS, Potter JD, Ulrich CM.
Cancer Epidemiology, Biomarkers and Prevention 2010; 19:547-57.

Intentional weight loss and risk of lympohematopoietic cancer.
De Roos AJ, Ulrich CM, Ray RM, Mossavar-Rahmani Y, Rosenberg CA, Caan B, Thomson C, McTiernan A, Lacroix A.
Cancer Causes Control 2010; 21:223-36.

The effects of obesity and obesity-related conditions of colorectal cancer prognosis.
Siegel EM, Ulrich CM, Poole EM, Holmes R, Jacobsen PB, Shibata D.
Cancer Control: Journal of the Moffitt Cancer Center 2010;17:52-57.

Genes involved with folate uptake and distribution and their association with colorectal cancer risk.
Figueiredo JC, Levine JA, Lee WH, Conti DV, Poynter JN, Campbell PT, Duggan D, Lewinger JP, Martinez ME, Ulrich CM, Newcomb P, Potter JD, Limburg PJ, Hopper J, Jenkins MA, LeMarchand L, Baron JA, Haile RW.
Cancer Causes & Control 2010;21:597-608.

Use of pathway information in molecular epidemiology.
Thomas DC, Conti DV, Baurley J, Nijhout F, Reed M, Ulrich CM.
Human Genomics 2009; 4:21-42.

MTHFR C677T and postmenopausal breast cancer risk by intakes of one-carbon metabolism nutrients: a nested case-control study.
Maruti SS, Ulrich CM, Jupe ER, White E.
Breast Cancer Research 2009;11:R91.

Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer.
Curtin K, Samowitz WS, Wolff RK, Ulrich CM, Caan BJ, Potter JD, Slattery ML.
Cancer Epidemiology, Biomarkers and Prevention 2009;18:3384-3388.

Higher habitual intake of dietary fat and carbohydrates are associated with lower leptin and higher ghrelin concentrations in overweight and obese postmenopausal women with elevated insulin levels.
Kong A, Neuhouser ML, Xiao L, Ulrich CM, McTiernan A, Foster-Schubert KE.
Nutrition Research 2009;29:768-776.

Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk.
Dong LM, Ulrich CM, Hsu L, Duggan DJ, Benitez DS, White E, Slattery ML, Farin F, Makar K, Carlson C, Caan BJ, Potter JD, Peters U.
Cancer Epidemiol, Biomarkers Prev. 2009 Sep;18(9):2540-8. Epub 2009 Aug 25.

MSH6 G39E polymorphism and CpG island methylator phenotype in colon cancer.
Curtin K, Samowitz WS, Wolff RK, Caan BJ, Ulrich CM, Potter JD, Slattery ML.
Molecular Carcinogenesis 2009;48:989-94.

TGF-ß receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a ß-catenin-independent pathway.
Trobridge P, Knoblaugh S, Washington MK, Munoz NM, Tsuchiya KD, Rojas A, Song X, Ulrich CM, Sasazuki, Shirasawa, Grady WM.
Gastroenterology 2009;136:1680-1688.

A mathematical model gives insights into the effects of vitamin B-6 deficiency on one-carbon and glutathione metabolism.
Nijhout HF, Gregory JF, Fitzpatrick C, Cho E, Lamers Y, Ulrich CM, Reed MC. 
Journal of Nutrition 2009;139(4): 784-91.

Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients.
Pierce BL**, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH, Baumgartner KB, Gilliland FD, Sorensen BE, McTiernan A, Ulrich CM.
Journal of Clinical Oncology 2009: 27:3437-44.

A yearlong exercise intervention decreases CRP among obese postmenopausal women.
Campbell PT**, Campbell KL, Wener MH, Wood BL, Potter JD, McTiernan A, Ulrich CM.
Medicine and Science in Sports and Exercise 2009;41(8):1533-39.

Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk.
Maruti SS, Ulrich CM, White E. 
American Journal of Clinical Nutrition 2009;89:624-33.

Mismatch repair polymorphisms and risk of colon cancer, tumor microsatellite instability, and interactions with lifestyle factors.
Campbell PT**, Curtin K, Ulrich CM, Samowitz WS, Bigler J, Velicer CM, Caan B, Potter JD, Slattery ML.
Gut 2009 May;58(5):661-7.

Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors.
Pierce BL**, Neuhouser ML, Wener MH, Bernstein L, Baumgartner RN, Ballard-Barbash R, Gilliland FD, Baumgartner KB, Sorensen B, McTiernan A, Ulrich CM.
Breast Cancer Research and Treatment 2009;114:155-67.

Proximity to traffic, inflammation and immune function among women in the Seattle, Washington, area.
Williams L, Ulrich CM, Larson T, Wener MH, Wood B, Potter JD, McTiernan A, DeRoos AJ.
Environmental Health Perspectives 2009;117:373-378.

Breast cancer survivors who use estrogenic botanical supplements have lower serum estrogen levels than non users.
Wayne SJ, Neuhouser ML, Koprowski C, Ulrich CM, Wiggins C, Gilliland F, Baumgartner KB, Baumgartner RN, McTiernan A, Bernstein L, Ballard-Barbash R.
Breast Cancer Research and Treatment 2009;117:111-9.

C-reactive protein genotypes and haplotypes, polymorphisms in NSAID-metabolizing enzymes, and risk of colorectal polyps.
Poole EM**, Bigler J, Whitton J, Sibert JG, Carlson CS, Potter JD, Ulrich CM
Pharmacogenetics and Genomics 2009;19:113-20.

A pilot study of sampling subcutaneous adipose tissue to examine biomarkers of cancer risk.
Campbell KL**, Makar KW, Kratz M, Foster-Schubert KE, McTiernan A, Ulrich CM.
Cancer Prevention Research 2009;2:37-42.

The association between alcohol intake and serum sex hormones and peptides differs by tamoxifen use in breast cancer survivors.
Wayne S, Neuhouser ML, Ulrich CM, Koprowski C, Wiggins C, Baumgartner KB, Bernstein L, Baumgartner RN, Gilliland F, McTiernan A, Ballard-Barbash R.
Cancer Epidemiology, Biomarkers and Prevention 2008;17:3224-32.

Serum leptin concentrations and markers of immune function in overweight and obese postmenopausal women.
Meyers JA**, McTiernan A, Wener MH, Wood B, Weigle DS, Sorensen B, Chen-Levy Z, Yasui Y, Boynton A, LaCroix K, Potter JD, Ulrich CM.
Journal of Endocrinology 2008;199:51-60

Genetic variation in calcium-sensing receptor and risk for colon cancer.
Dong L, Ulrich CM, Hsu L, Duggan DJ, Benitez DS, White E, Slattery ML, Caan BJ, Potter JD, Peters U.
Cancer Epidemiology, Biomarkers, and Prevention 2008;17:2755-65.

The MLH1 -93 G>A promoter polymorphism and genetic and epigenetic alterations in colon cancer.
Samowitz WS, Curtin K, Wolff RK, Albertsen H, Sweeney C, Caan BJ, Ulrich CM, Potter JD, Slattery ML.
Genes, Chromosomes, and Cancer 2008;47:835-44.

Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors.
Neuhouser ML, Sorensen B, Hollis BW, Ambs A, Ulrich CM, McTiernan A, Bernstein L, Wayne S, Gilliland F, Baumgartner K, Baumgartner R, Ballard-Barbash R.
American Journal of Clinical Nutrition 2008;88:133-9.

Mathematical modeling of folate metabolism: Predicted effects of genetic polymorphisms on mechanisms and biomarkers relevant to carcinogenesis.
Ulrich CM, Neuhouser M, Liu AY, Boynton A, Gregory JG 3rd, Shane BS, James SJ, Reed MC, Nijhout HF. 
Cancer Epidemiology, Biomarkers, and Prevention 2008;17:1822-31.

Folate and cancer prevention: where to next? (editorial)
Ulrich CM.
Cancer Epidemiology, Biomarkers and Prevention 2008;17:2226-30.

Modeling folate, one-carbon metabolism, and DNA methylation.
Ulrich CM, Reed MC, Nijhout HF.
Nutrition Reviews 2008;66:S27-30.

Dietary fiber is associated with serum sex hormones, insulin-related peptides, and leptin in postmenopausal breast cancer survivors.
Wayne SJ, Neuhouser ML, Ulrich CM, Koprowski C, Baumgartner KB, Baumgartner RN, McTiernan A, Bernstein L, Ballard-Barbash.
Breast Cancer Research & Treatment 2008;112:149-58.

A review of gene-drug interactions for non-steroidal anti-inflammatory drug (NSAID) use in preventing colorectal neoplasia.
Cross JT**, Poole EM**, Ulrich CM.
The Pharmacogenomics Journal 2008;8:237-47.

No reduction in C-reactive protein following a 12-month randomized controlled trial of exercise in men and women.
Campbell KL, Campbell PT, Ulrich CM, Wener MW, Alfano CM, Foster-Schubert KE, Rudolph RE, Potter JD, McTiernan A.
Cancer Epidemiology, Biomarkers and Prevention 2008;17:1714-8.

Does folic-acid supplementation prevent or promote colorectal cancer? Results from model-based predictions.
Luebeck EG, Moolgavkar SH, Boynton A, Liu AY, Ulrich CM.
Cancer Epidemiology, Biomarkers, and Prevention 2008;17:1360-7.

Effect of exercise on immune function: a 12-month randomized controlled trial among postmenopausal women.
Campbell PT**, Wener MH, Sorensen B, Wood B, Potter JD, McTiernan A, Ulrich CM.
Journal of Applied Physiology 2008;104:1648-55.

Shedding light on colorectal cancer prognosis – vitamin D and beyond.
Ulrich CM, Holmes RS.
Journal of Clinical Oncology 2008;26:2937-9

Genetic susceptibility to cancer: the role of polymorphisms in candidate genes.
Dong LM, Potter JD, White E, Ulrich CM, Cardon LR, Peters U.
JAMA 2008;229:2423-36.

A mathematical model of glutathione metabolism.
Reed MC, Thomas RL, Pavisic J, James SJ, Ulrich CM, Nijhout HF.
Theoretical Biology & Medical Modelling 2008;5:8. doi: 10.1186/1742-4682-5-8.

Effect of exercise on serum sex hormones in men: A 12-month randomized controlled clinical trial.
Hawkins V, Foster-Schubert KE, Chubak J, Sorensen B, Ulrich CM, Stanczyk FZ, Plymate S, Stanford JL, White E, Potter JD, McTiernan A.
Medicine and Science in Sports and Exercise 2008;40:223-33.

DNA methyltransferase and alcohol dehydrogenase: gene-nutrient interactions in relation to risk of colorectal polyps.
Jung AY**, Poole EM, Bigler J, Whitton J, Potter JD, Ulrich CM.
Cancer Epidemiology, Biomarkers and Prevention 2008;17:330-8.

Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review.
Velicer CM**, Ulrich CM.
Journal of Clinical Oncology 2008;26:665-73.

Predictors of diet quality among overweight or obese postmenopausal women.
Boynton AM**, Neuhouser ML, Sorensen B, McTiernan A, Ulrich CM.
Journal of the American Dietetic Association 2008;108:125-30.

Predictors of diet quality among overweight or obese postmenopausal women.
Boynton AM**, Neuhouser ML, Sorensen B, McTiernan A, Ulrich CM.
Journal of the American Dietetic Association 2008;108:125-30.

A day in the life of cell metabolism.
Nijhout HF, Reed MC, Ulrich CM.
Biological Theory 2007;2:124-7.

No effect of exercise on colon mucosal prostaglandin concentrations: A 12-month randomized controlled trial.
Abrahamson PE, King I, Sorensen B, Potter JD, Lampe J, Yasui Y, Ulrich CM, McTiernan A.
Cancer Epi Biomarkers Prev 2007;16:2351-6.

Associations between healthy eating patterns and immune function in postmenopausal women.
Boynton AM**, Neuhouser ML, Wener MH, Wood B, Sorensen B, Chen-Levy Z, Kirk EA, Yasui Y, LaCroix K, McTiernan A, Ulrich CM.
American Journal of Clinical Nutrition 2007;86:1445-55.

Effect of a 12-month exercise intervention on the apoptotic regulating proteins Bax and Bcl-2 in colon crypts: a randomized controlled trial.
Campbell KL, McTiernan A, Li SS, Sorensen BE, Yasui Y, Lampe JW, King IB, Ulrich CM, Rudolph RE, Irwin ML, Surawicz C, Ayub K, Potter JD, Lampe PD.
Cancer Epidemiology, Biomarkers, and Prevention 2007;16:1767-74.

Effects of an exercise intervention on other health behaviors in overweight/obese post-menopausal women.
Rhew I, Yasui Y, Sorensen B, Ulrich CM, Neuhouser M, Potter JD, Tworoger SS, Chubak, Bowen DJ, McTiernan A.
Contemp Clin Trials. 2007 Jul; 28(4): 472-81. Epub 2007 Jan 12.

Folate and cancer prevention – a closer look at a complex picture (editorial).
Ulrich CM.
Am J Clin Nutr 2007;86:271-273.

Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet.
Curtin K, Slattery ML, Ulrich CM, Bigler J, Levin TR, Wolff RK, Albertsen H, Potter JD, Samowitz WS.
Carcinogenesis 2007; 28(8): 1672-79.

Folate and cancer – timing is everything (editorial).
Ulrich CM, Potter JD.
JAMA 2007;297:2408-9

Genetic variability in prostaglandin synthesis, fish intake, and risk of colorectal polyps.
Poole EM**, Bigler J, Whitton J, Sibert JG, Kulmacz RJ, Potter JD, Ulrich CM.
Carcinogenesis 2007;28:1259-63.

Effect of a 12-month randomized clinical trial of exercise on serum prolactin concentrations in postmenopausal women.
Tworoger SS, Sorensen B, Chubak J, Irwin M, Stanczyk FZ, Ulrich CM, Potter JD, McTiernan A.
Cancer Epidemiology, Biomarkers and Prevention 2007;16:895-99.

Thymidylate synthase polymorphisms and colon cancer: associations with tumor stage, tumor characteristics, and survival.
Curtin K**, Ulrich CM, Bigler J, Samowitz WS, Caan B, Potter JD, Slattery ML.
Int J Cancer 2007;120:2226-32.

Associations between the CYP17, CYPIB1, COMT and SHBG polymorphisms and serum sex hormones in postmenopausal breast cancer survivors.
Abrahamson PE, Tworoger SS, Aiello EJ, Ulrich CM, Gilliland FD, Stanczyk FZ, Baumgartner R, Bernstein L, Sorensen B, Ballard-Barbash R, McTiernan A.
Breast Cancer Research and Treatment 2007; 105: 45-54.

DNA alkylation and DNA methylation: cooperating mechanisms driving colorectal carcinogenesis. (commentary)
Grady WM, Ulrich CM.
Gut 2007;56:318-20.

Polymorphisms predicted to alter function in prostaglandin E2 synthase and prostaglandin E2 receptors.
Bigler J, Sibert JG, Poole EM, Carlson CS, Potter JD, Ulrich CM.
Pharmacogenetics 2007;17:221-7.

Sleep, ghrelin, leptin, and changes in body weight during a 1-year moderate-intensity physical activity intervention.
Littman AJ, Vittielo MV, Foster-Schubert K, Ulrich CM, Tworoger SS, Potter JD, Weigle DS, McTiernan A.
International Journal of Obesity 2007;31:466-75.

Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics.
Ulrich CM, Bigler J, Potter JD.
Nature Reviews Cancer 2006;6:130-140, reprinted in Nature Reviews Cancer, Biomarkers Collection, 2007:S23-33

In silico experimentation with a model of hepatic mitochondrial folate metabolism.
Nijhout HF, Reed MC, Lam SL, Shane B, Gregory JF, Ulrich CM.
Theoretical Biology and Medical Modeling 2006;3:40 doi:10.1186/1742-4682-3-40.

Effects of physical activity on quality of life in sedentary middle aged women.
Bowen DJ, Fesinmeyer MD, Yasui Y, Tworoger SS, Ulrich CM, Irwin ML, Rudolph RE, LaCroix KL, Schwartz RR, McTiernan A.
International Journal of Behavioral Nutrition and Physical Activity 2006;3:34.

Moderate-intensity exercise reduces the incidence of colds among postmenopausal women.
Chubak J**, McTiernan A, Sorensen B, Wener MH, Yasui Y, Velasquez M, Wood B, Rajan KB, Wetmore CM, Potter JD, Ulrich CM.
American Journal of Medicine 2006;119:937-42.

A mathematical model gives insights into nutritional and genetic aspects of folate-mediated one-carbon metabolism.
Reed MC, Nijhout HF, Neuhouser ML, Gregory JF IIIrd, Shane B, James SJ, Boynton A, Ulrich CM.
Journal of Nutrition 2006;136:2653-2661.

Methylenetetrahydrofolate reductase and thymidylate synthase genotypes and risk of acute graft-vs-host disease following hematopoietic cell transplant for chronic myelogenous leukemia.
Robien K**, Bigler J, Yasui Y, Potter JD, Martin P, Storb R, Ulrich CM.
Biology of Blood and Marrow Transplantation 2006;12:973-80.

Nucleotide excision repair genotype and the incidence of endometrial cancer: effect of other risk factors on the association.
Weiss JM**, Weiss NS, Ulrich CM, Doherty JA, Chen C.
Gynecologic Oncology 2006;103:891-6.

Genetic tools to tailor cancer prevention by NSAIDs.
Ulrich CM, Bigler J, Potter JD.
Discovery Medicine 2006;6:71-4.

DNA damage and repair measurements from cryopreserved lymphocytes without cell culture – a reproducible assay for intervention assays.
Chang JL**, Chen G, Lampe JW, Ulrich CM.
Environmental and Molecular Mutagenesis 2006;47:503-8.

COX-2 and gastric cancer: more on inflammation and neoplasia (editorial).
Potter JD, Ulrich CM.
Gastroenterology 2006;130:2198-2200.

Mathematical modeling: epidemiology meets systems biology (editorial).
Ulrich CM, Nijhout HF, Reed MC.
Cancer Epidemiology, Biomarkers, and Prevention 2006;15:827-9.

New developments in the epidemiology of cancer prognosis: Traditional and molecular predictors of treatment response and survival.
Ambrosone CB, Rebbeck TR, Morgan GJ, Albain KS, Calle EE, Evans WE, Hayes DF, Kushi LH, McLeod HL, Rowland JH, Ulrich CM.
Cancer Epidemiology, Biomarkers, and Prevention 2006;15:2042-6.

Effect of exercise on bone mineral density, and lean mass in postmenopausal women.
Chubak J, Ulrich CM, Tworoger SS, Sorensen B, Yasui Y, Irwin ML, Stanczyk FZ, Potter JD, McTiernan A.
Medicine and Science in Sports and Exercise 2006;38:1236-44.

Mismatch repair polymorphisms and colorectal polyps: hMLH1 -93G>A variant modifies risk associated with smoking.
Yu JH**, Bigler J, Whitton J, Potter JD, Ulrich CM.
American Journal of Gastroenterology 2006;101:1313-9.

Long-range allosteric interactions between the folate and methionine cycles stabilize DNA methylation reaction rate.
Nijhout HF, Reed M, Anderson D, Mattingly J, James SJ, Ulrich CM.
Epigenetics 2006;1:81-7.

Methylenetetrahydrofolate reductase and thymidylate synthase genotypes modify oral mucositis severity following hematopoietic stem cell transplantation (letter).
Robien K**, Schubert MM, Chay T, Bigler J, Storb R, Yasui Y, Potter JD, Ulrich CM.
Bone Marrow Transplantation 2006;37:799-800.

Prostacyclin synthase and arachidonate 5-lipoxygenase polymorphisms and risk of colorectal polyps.
Poole EM**, Bigler J, Whitton J, Potter JD, Sibert JG, Ulrich CM.
Cancer Epidemiology, Biomarkers, and Prevention 2006;15:502-8.

Folic acid supplementation during methotrexate immunosuppression is not associated with early toxicity, risk of acute graft-vs-host disease or relapse following hematopoietic transplantation.
Robien K**, Schubert MM, Yasui Y, Martin P, Storb R, Potter JD, Ulrich CM.
Bone Marrow Transplantation 2006;37:687-92.

Serum lipoproteins in overweight/obese postmenopausal women: a one year exercise trial.
Mohanka M, Irwin M, Heckbert SR, Yasui Y, Sorensen B, Chubak J, Tworoger SS, Ulrich CM, McTiernan A.
Medicine Science, Sports & Exercise 2006;38:231-9.

Folate supplementation – too much of a good thing? (editorial).
Ulrich CM, Potter JD.
Cancer Epidemiology, Biomarkers, and Prevention 2006;15:189-93.

Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women.
Troen AM**, Mitchell B, Sorensen B, Wener MH, Johnston A, Wood B, Selhub J, McTiernan A, Yasui Y, Potter JD, Ulrich CM.
Journal of Nutrition 2006;136:189-94.

Interindividual variation in nucleotide excision repair genes and risk of endometrial cancer.
Weiss JM, Weiss NS, Ulrich CM, Doherty JA, Voigt LF, Chen C.
Cancer Epidemiology, Biomarkers, and Prevention 2005;14:2524-30.

Pharmacogenetics of folate-related drug targets in cancer treatment.
Robien K**, Boynton A**, Ulrich CM.
Pharmacogenomics 2005;6:673-89.

DNA repair polymorphisms and risk of colorectal adenomatous or hyperplastic polyps.
Bigler J, Ulrich CM, Kawashima T, Whitton J, Potter JD.
Cancer Epidemiology, Biomarkers, and Prevention 2005;14:2501-8.

Leptin and immune function – integrating the evidence.
Meyers JA**, McTiernan A, Ulrich CM.
Nutrition Research 2005;9:791-803.

Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase, and risk of colon cancer.
Ulrich CM*, Curtin K*, Potter JD, Bigler J, Caan B, Slattery ML.
Cancer Epidemiology, Biomarkers, and Prevention 2005;14:2509-16. *These authors contributed equally.

MTHFR variants reduce the risk of G:C>A:T transition mutations within the p53 tumor suppressor gene in colon tumors.
Ulrich CM, Curtin K, Samowitz W, Bigler J, Potter JD, Caan B, Slattery ML.
Journal of Nutrition 2005;135:2462-7.

Nutrigenetics in cancer research – folate metabolism and colorectal cancer.
Ulrich CM.
Journal of Nutrition 2005;135:2689-702.

Thromboxane synthase (TBXAS1) polymorphisms in African-American and Caucasian populations – evidence for selective pressure?
Ulrich CM*, Carlson CS, Sibert J, Poole EM, Yu JH, Wang LH, Sparks R, Potter JD, Bigler J*.
Human Mutation 2005;26:394-5.*These authors contributed equally.

Associations between reproductive and menstrual factors and postmenopausal androgen concentrations.
Chubak J, Tworoger SS, Yasui Y, Ulrich CM, Stanczyk FZ, McTiernan A.
Journal of Women’s Health 2005:14;704-12.

Associations among circulating sex hormones, insulin-like growth factors, lipids, and mammographic density in postmenopausal women.
Aiello EJ, Tworoger SS, Yasui Y, Stanczyk FZ, Potter JD, Ulrich CM, Irwin M, McTiernan A.
Cancer Epidemiology, Biomarkers, and Prevention 2005;14:1411-7.

Microsomal epoxide hydrolase polymorphisms are not associated with colon cancer risk.
Robien K**, Curtin K, Ulrich CM, Bigler J, Samowitz W, Caan B, Potter JD, Slattery ML.
Cancer Epidemiology, Biomarkers, and Prevention 2005;14:1350-2.

Effects of exercise on metabolic risk variables in overweight postmenopausal women: a randomized clinical trial.
Frank LL, Sorensen BE, Yasui Y, Tworoger ST, Schwartz RS, Ulrich CM, Irwin ML, Rudolph RE, Rajan B, Stanczyk F, Bowen D, Weigle DS, Potter JD, McTiernan A.
Obesity Research 2005;13:615-25.

No effect of exercise on insulin-like growth factor 1 and insulin-like growth factor binding-protein 3 in postmenopausal women: a 12-month randomized clinical trial.
McTiernan A, Sorensen BE, Yasui Y, Tworoger ST, Ulrich CM, Irwin ML, Rebecca RE, Stanczyk FZ, Schwartz RS, Potter JD.
Cancer Epidemiology, Biomarkers and Prevention 2005;14:1020-1.

A Michaelis-Menten-style model for the autocatalytic enzyme Prostaglandin H Synthase.
Tien JH**, Hazelton WD, Sparks R, Ulrich CM.
Bulletin of Mathematical Biology 2005; 67:683-700.

PTGS2 (COX-2) –765G>C promoter variant reduces risk of colorectal adenoma among non-users of NSAIDs.
Ulrich CM, Whitton J, Yu J-H, Sibert J, Sparks R, Potter JD, Bigler J.
Cancer Epidemiology, Biomarkers and Prevention 2005;14:616-9.

Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature.
Weiss JM**, Goode EL, Ladiges WC, Ulrich CM.
Molecular Carcinogenesis 2005;42:127-41.

A mathematical model of the folate cycle – new insights into folate homeostasis.
Nijhout HF, Reed MC, Budu P, Ulrich CM.
Journal of Biological Chemistry 2004;279:55008-16.

Methylenetetrahydrofolate reductase genotype affects risk of relapse following hematopoietic cell transplantation for chronic myelogenous leukemia.
Robien K**, Ulrich CM, Bigler J, Yasui Y, Gooley T, Bruemmer B, Potter JD, Radich JR.
Clinical Cancer Research 2004;10:7592-8.

Influence of demographic, physiologic, and psychosocial variables on adherence to a yearlong moderate-intensity exercise trial in postmenopausal women.
Irwin ML, Tworoger SS, Yasui Y, Rajan B, McVarish L, LaCroix K, Ulrich CM, Bowen D, Schwartz RS, Potter JD, McTiernan A.
Preventive Medicine 2004;39:1080-6.

Associations between reproductive and menstrual factors and postmenopausal sex hormone concentrations.
Chubak J, Tworoger SS, Yasui Y, Ulrich CM, Stanczyk FZ, McTiernan A.
Cancer Epidemiology, Biomarkers and Prevention 2004;13:1296-1301.

Effect of exercise on serum androgens in postmenopausal women: a 12-month randomized clinical trial.
McTiernan A, Tworoger SS, Rajan B, Yasui Y, Ulrich CM, Chubak J, Stanczyk FZ, Bowen D, Irwin ML, Sorensen B, Rudolph RE, Potter JD, Schwartz RS.
Cancer Epidemiology, Biomarkers and Prevention 2004;13:1099-1105.

UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex-hormone concentrations, and tumor characteristics in breast cancer patients.
Sparks R**, Ulrich CM, Bigler J, Tworoger SS, Yasui Y, Rajan KB, Porter P, Stanczyk FZ, Ballard-Barbash R, Yuan X, Lin MG, McVarish L, Aiello E, McTiernan A.
Breast Cancer Research 2004;6:R488-98.

The effect of CYP19 and COMT polymorphisms on exercise-induced fat loss in postmenopausal women.
Tworoger SS, Chubak J, Aiello EJ, Yasui Y, Ulrich CM, Farin FM, Stapleton PL, Irwin ML, Potter JD, Schwartz RS, McTiernan A.
Obesity Research 2004;12:972-80.

Prostaglandin H synthases: members of a class of quasi-linear threshold switches.
Hazelton WD, Tien JH, Donato VW, Sparks R, Ulrich CM.
Biochemical Pharmacology 2004;68:423-32.

Effects of a moderate intensity exercise intervention on estrogen metabolism in postmenopausal women.
Atkinson C, Lampe JW, Tworoger SS, Ulrich CM, Bowen D, Irwin ML, Schwartz RS, Rajan BK, Yasui Y, Potter JD, McTiernan A.
Cancer Epidemiology, Biomarkers and Prevention 2004;13:868-74.

Effect of a yearlong moderate-intensity exercise intervention on the occurrence and severity of menopausal symptoms in postmenopausal women.
Aiello EJ, Yasui Y, Tworoger SS, Ulrich CM, Irwin ML, Bowen D, Schwartz RS, Kumai C, Potter JD, McTiernan A.
Menopause 2004;4:382-8.

Effect of exercise on serum estrogen in postmenopausal women: a 12-month randomized clinical trial.
McTiernan A, Tworoger SS, Ulrich CM, Yasui Y, Irwin ML, Rajan B, Rudolph RE, Bowen D, Stanczyk F, Potter JD, Schwartz RS.
Cancer Research 2004; 64: 2923-28.

Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia.
Robien K**, Schubert MM, Lloid ME, Bruemmer B, Potter JD, Ulrich CM.
Journal of Clinical Oncology 2004;22:1268-75.

Polymorphisms in PTGS1 (=COX-1) and risk of colorectal polyps.
Ulrich CM, Bigler J, Sparks R, Whitton J, Sibert JG, Goode EL, Yasui Y, Potter JD.
Cancer Epidemiology, Biomarkers and Prevention 2004;13:889-93.

TGFb1 polymorphism (L10P) and risk of colorectal adenomatous and hyperplastic polyps.
Sparks R**, Bigler J, Sibert JG, Potter JD, Yasui Y, Ulrich CM.
International Journal of Epidemiology 2004;33:1-7.

MTHFR C677T and A1298C polymorphisms – diet, estrogen, and risk of colon cancer.
Curtin K, Bigler J, Slattery ML, Caan B, Potter JD, Ulrich CM.
Cancer Epidemiology, Biomarkers and Prevention 2004;13:285-92.

Methionine synthase D919G polymorphism, folate metabolism, and colorectal adenoma risk.
Goode EL**, Potter JD, Bigler J, Ulrich CM.
Cancer Epidemiology, Biomarkers, and Prevention 2004;13:157-62.

A mathematical model of the methionine cycle.
Reed MC, Nijhout HF, Sparks R, Ulrich CM.
Journal of Theoretical Biology 2004;226:33-43.

Frequent intentional weight loss is associated with lower natural killer cell cytotoxicity constituting possible long-term effects on immune function.
Shade ED**, McTiernan A, Wener MH, Wood B, Yasui Y, LaCroix K, Potter JD, Ulrich CM.
Journal of the American Dietetic Association 2004;104:903-12.

Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women.
Tworoger SS, Chubak J, Aiello EJ, Ulrich CM, Atkinson C, Potter JD, Yasui Y, Stapleton PL, Lampe J, Farin FM, Stanczyk FZ, McTiernan A.
Cancer Epidemiology, Biomarkers and Prevention 2004;13:94-101.

Cancer pharmacogenetics: Polymorphisms, pathways, and beyond.
Ulrich CM, Robien K, McLeod H.
Nature Reviews Cancer 2003;12:912-20.

Effects of a yearlong moderate-intensity exercise and a stretching intervention on sleep quality in postmenopausal women.
Tworoger SS, Yasui Y, Vitiello M, Schwartz RS, Ulrich CM, Aiello EJ, Irwin ML, Bowen D, Potter JD, McTiernan A.
Sleep 2003;26:830-6.

Hyperinsulinemia and hyperglycemia: Possible risk factors of colorectal cancer among diabetic patients.
Chang CK**, Ulrich CM.
Diabetologia 2003;46:595-609.

Managed care and primary physician satisfaction.
Grembowski D, Ulrich CM, Paschane D, Diehr P, Katon W, Martin D, Patrick DL, Velicer C.
Journal of the American Board of Family Practice 2003;16:383-93.

Supplementation with vitamins or minerals and immune function: Can the elderly benefit?
Mitchell BL**, Ulrich CM, McTiernan A.
Nutrition Research 2003;23:1117-39.

5,10-methylenetetrahydrofolate reductase polymorphisms and leukemia risk: A HuGE minireview.
Robien K**, Ulrich CM.
American Journal of Epidemiology 2003;157:571-82.

Effect of exercise on total and intra-abdominal body fat in postmenopausal women: A randomized controlled trial.
Irwin ML, Yasui Y, Ulrich CM, Bowen D, Rudolph RE, Schwartz RS, Yukawa M, Aiello E, Potter JD, McTiernan A.
JAMA 2003;289:323-30.

Polymorphisms in DNA repair genes and associations with cancer risk (review).
Goode EL**, Ulrich CM, Potter JD.
Cancer Epidemiology, Biomarkers and Prevention 2002;11:1513-30.

Cyclooxygenase 1 (COX-1) polymorphisms in African-American and Caucasian populations.
Ulrich CM, Bigler J, Sibert J, Greene EA, Sparks R, Carlson CS, Potter JD.
Human Mutation 2002;20:409-10.

Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential?
Morimoto LM, Newcomb PA, Ulrich CM, Bostick RM, Lais CL, Potter JD.
Cancer Epidemiology, Biomarkers and Prevention 2002;11:1012-8.

Thymidylate Synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenoma.
Ulrich CM, Bigler J, Bostick R, Fosdick L, Potter JD.
Cancer Research 2002;62:3361-4.

Pharmacogenetics and folate metabolism – a promising direction (invited review).
Ulrich CM, Robien K**, Sparks R**.
Pharmacogenomics 2002;3:299-313.

Mailing strategies and recruitment into an intervention trial of the exercise effect on breast cancer biomarkers.
Tworoger SS, Yasui Y, Ulrich CM, Nakamura H, LaCroix K, Johnston R, McTiernan A.
Cancer Epidemiology Biomarkers Prevention 2002;11:73-7.

Vitamin D receptor polymorphisms and the risk of colorectal adenomas: evidence of interaction with dietary vitamin D and calcium.
Kim HS, Newcomb PA, Ulrich CM, Keener CL, Farin FM, Bostick RM, Potter JD
Cancer Epidemiology, Biomarkers and Prevention 2001;10:869-74.

Epoxide hydrolase Tyr113His polymorphism is associated with elevated risk of colorectal polyps in the presence of smoking and high meat intake.
Ulrich CM, Bigler J, Whitton JA, Bostick R, Fosdick L, Potter JD.
Cancer Epidemiology, Biomarkers and Prevention 2001;10:875-82.

Pharmacogenetics of methotrexate: Toxicity among marrow transplantation patients varies with the 5,10-methylenetetrahydrofolate reductase C677T polymorphism.
Ulrich CM, Yasui Y, Storb R, Schubert MM, Wagner JL, Bigler J, Ariail KS, Keener CL, Li S, Liu H, Farin FM, Potter JD.
Blood 2001;98:231-4.

Searching expressed sequence tag (EST) databases: Discovery and confirmation of a common polymorphism in the thymidylate synthase gene.
Ulrich CM, Bigler J, Velicer CM, Greene EA, Farin F, Potter JD.
Cancer Epidemiology, Biomarkers and Prevention 2000;12:1381-1385.

Measuring the “managedness” and covered benefits of health plans.
Grembowski DE, Diehr P, Novak LC, Roussel AE, Martin DP, Patrick DL, Williams B, Ulrich CM.
Health Services Research 2000;35(3):707-34.

Lack of association between the C677T MTHFR polymorphism and colorectal hyperplastic polyps.
Ulrich CM, Kampman E, Bigler J, Schwartz S, Chen C, Bostick R, Fosdick L, Beresford SAA, Yasui Y, Potter JD.
Cancer Epidemiology Biomarkers and Prevention 2000;9:427-433.

The PATH Study: Rationale and study design.
McTiernan A, Ulrich CM, Yancey D, Slate S, Bowen D, Nakamura H, Schwartz R, Potter JD.
Medicine and Science in Sports and Exercise 1999;31(9):1307-1312.

Colorectal adenomas and the C677T MTHFR polymorphism: Evidence for gene-environment interaction?
Ulrich CM, Kampman E, Bigler J, Schwartz S, Chen C, Bostick R, Fosdick L, Beresford SAA, Yasui Y, Potter JD.
Cancer Epidemiology Biomarkers and Prevention 1999; 8(8):659-668.

Lifetime physical activity is associated with bone mineral density in premenopausal women.
Ulrich CM, Georgiou CC, Gillis DE, Snow CM.
Journal of Women’s Health 1999;8(3):365-375.

Genetic testing for cancer risk: A population survey on attitudes and intention.
Ulrich CM, Kristal AR, White E, Durfy SJ, Hunt JR, Potter JD.
Community Genetics 1998;1:213-222.

Physical activity and cancer etiology: associations and mechanisms (review).
McTiernan A, Ulrich C, Slate S, Potter JD. 
Cancer Causes and Control, 1998;9:487-509.

Akzeptanz genetischer Tests in der Bevölkerung.
Röttger-Liepmann B, Ulrich CM, Laaser U. 
Fortschritte der Medizin, 1998; 116(27):43.

Telefonische Befragung zu genetischen Tests für Brust- und Prostatakrebsrisiko.
Röttger-Liepmann B, Ulrich CM, Laaser U.
Fortschritte der Medizin, 1998; 116(Suppl 3):95-99.

Anthropometric and Hormone Effects of an 8-Week Exercise-Diet Intervention in Breast Cancer Patients: Results of a Pilot Study.
McTiernan A, Ulrich CM, Kumai C, Bean D, Schwartz R, Mahloch J, Hastings R, Gralow J, Potter JD. 
Cancer Epidemiology, Biomarkers and Prevention 1998; 7:477-481.

Bone mineral density in mother-daughter pairs: relations to lifetime exercise, lifetime milk consumption, and calcium supplements.
Ulrich CM, Georgiou CC, Snow-Harter CM, Gillis, D. 
American Journal of Clinical Nutrition 1996;63:72-9.